Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Colby

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
Journal of Virus Eradication|August 3, 2016
Factors associated with HIV viral load suppression on antiretroviral therapy in VietnamSuresh Rangarajan, J Colby Donn, Le Truong Giang, et al.
The Journal of Clinical Investigation|February 5, 2020
Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruptionJulie L Mitchell, Hiroshi Takata, Roshell Muir, et al.
Med (New York, N.Y.)|July 23, 2022
Acute HIV-1 infection viremia associate with rebound upon treatment interruptionThembi Mdluli, Yifan Li, Suteeraporn Pinyakorn, et al.
Science Translational Medicine|March 6, 2020
Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infectionLouise Leyre, Eugène Kroon, Claire Vandergeeten, et al.
Nature Medicine|June 13, 2018
Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infectionDonn J Colby, Lydie Trautmann, Suteeraporn Pinyakorn, et al.
Cell Reports|June 8, 2024
Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruptionThembi Mdluli, Bonnie M Slike, Daniel J Curtis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2020
Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency VirusJoanna Hellmuth, Camilla Muccini, Donn J Colby, et al.
The Journal of Clinical Investigation|September 21, 2023
Initial productive and latent HIV infections originate in vivo by infection of resting T cellsStephen W Wietgrefe, Jodi Anderson, Lijie Duan, et al.
Ebiomedicine|September 11, 2022
Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8<sup>+</sup> T cellsHiroshi Takata, Juyeon C Kakazu, Julie L Mitchell, et al.
Journal of Virus Eradication|November 30, 2020
A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infectionEugène D M B Kroon, Jintanat Ananworanich, Amélie Pagliuzza, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Journal of Virus Eradication|August 3, 2016
Factors associated with HIV viral load suppression on antiretroviral therapy in VietnamSuresh Rangarajan, J Colby Donn, Le Truong Giang, et al.
The Journal of Clinical Investigation|February 5, 2020
Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruptionJulie L Mitchell, Hiroshi Takata, Roshell Muir, et al.
Med (New York, N.Y.)|July 23, 2022
Acute HIV-1 infection viremia associate with rebound upon treatment interruptionThembi Mdluli, Yifan Li, Suteeraporn Pinyakorn, et al.
Science Translational Medicine|March 6, 2020
Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infectionLouise Leyre, Eugène Kroon, Claire Vandergeeten, et al.
Nature Medicine|June 13, 2018
Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infectionDonn J Colby, Lydie Trautmann, Suteeraporn Pinyakorn, et al.
Cell Reports|June 8, 2024
Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruptionThembi Mdluli, Bonnie M Slike, Daniel J Curtis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2020
Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency VirusJoanna Hellmuth, Camilla Muccini, Donn J Colby, et al.
The Journal of Clinical Investigation|September 21, 2023
Initial productive and latent HIV infections originate in vivo by infection of resting T cellsStephen W Wietgrefe, Jodi Anderson, Lijie Duan, et al.
Ebiomedicine|September 11, 2022
Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8<sup>+</sup> T cellsHiroshi Takata, Juyeon C Kakazu, Julie L Mitchell, et al.
Journal of Virus Eradication|November 30, 2020
A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infectionEugène D M B Kroon, Jintanat Ananworanich, Amélie Pagliuzza, et al.
Pageof 15